Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interleukin, tumor necrosis factor-α and C-reactive protein profiles in melancholic and non-melancholic depression: A systematic review
Chenghao Yang, Kim M. Tiemessen, Fokko J. Bosker, et al.
Journal of Psychosomatic Research (2018) Vol. 111, pp. 58-68
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Role of Interleukin-6 in Depressive Disorder
Emily Yi-Chih Ting, Albert C. Yang, Shih‐Jen Tsai
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2194-2194
Open Access | Times Cited: 284
On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?
Elnaz Roohi, Nématollah Jaafari, Farshad Hashemian
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 142
Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review
Chenghao Yang, Klaas J. Wardenaar, Fokko J. Bosker, et al.
Journal of Affective Disorders (2019) Vol. 257, pp. 640-649
Open Access | Times Cited: 120
Depression profilers and immuno-metabolic dysregulation: Longitudinal results from the NESDA study
Femke Lamers, Yuri Milaneschi, Christiaan H. Vinkers, et al.
Brain Behavior and Immunity (2020) Vol. 88, pp. 174-183
Open Access | Times Cited: 113
Depression: Biological markers and treatment
Gordana Nedić Erjavec, Marina Šagud, Matea Nikolac Perković, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 105, pp. 110139-110139
Closed Access | Times Cited: 88
An inflammatory profile linked to increased suicide risk
Sarah A. Keaton, Zachary Madaj, Patrick L. Heilman, et al.
Journal of Affective Disorders (2019) Vol. 247, pp. 57-65
Open Access | Times Cited: 81
Inflammation in obsessive–compulsive disorder: A literature review and hypothesis‐based potential of transcranial photobiomodulation
David Richer Araujo Coelho, Joshua D. Salvi, Willians Fernando Vieira, et al.
Journal of Neuroscience Research (2024) Vol. 102, Iss. 3
Closed Access | Times Cited: 12
The effect of GLP-1RAs on mental health and psychotropics-induced metabolic disorders: A systematic review
Sigrid Breit, Daniela Hubl
Psychoneuroendocrinology (2025), pp. 107415-107415
Closed Access | Times Cited: 1
The role of microbiota and inflammation in self-judgement and empathy: implications for understanding the brain-gut-microbiome axis in depression
Nadja Heym, Bryony Heasman, Kirsty Hunter, et al.
Psychopharmacology (2019) Vol. 236, Iss. 5, pp. 1459-1470
Open Access | Times Cited: 74
No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial
Bernhard T. Baune, Emma Sampson, Jennie Louise, et al.
European Neuropsychopharmacology (2021) Vol. 53, pp. 34-46
Closed Access | Times Cited: 44
Overview of First-Line and Second-Line Pharmacotherapies for Osteoarthritis with Special Focus on Intra-Articular Treatment
Alicja Nowaczyk, Dawid Szwedowski, Ignácio Dallo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1566-1566
Open Access | Times Cited: 36
Peripheral Inflammatory Markers in Subtypes and Core Features of Depression: A Systematized Review
Pavel Křenek, Jana Hořínková, Elis Bartečků
Psychopathology (2023) Vol. 56, Iss. 5, pp. 403-416
Open Access | Times Cited: 16
White matter integrity and pro-inflammatory cytokines as predictors of antidepressant response in MDD
Sigrid Breit, Elena Mazza, Sara Poletti, et al.
Journal of Psychiatric Research (2023) Vol. 159, pp. 22-32
Open Access | Times Cited: 14
Linking atypical depression and insulin resistance-related disorders via low-grade chronic inflammation: Integrating the phenotypic, molecular and neuroanatomical dimensions
Zümrüt Duygu Şen, Lena Vera Danyeli, Marie Woelfer, et al.
Brain Behavior and Immunity (2020) Vol. 93, pp. 335-352
Open Access | Times Cited: 39
Unlocking the Secrets: Exploring the Biochemical Correlates of Suicidal Thoughts and Behaviors in Adults with Autism Spectrum Conditions
Ivan Mirko Cremone, Benedetta Nardi, Giulia Amatori, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1600-1600
Open Access | Times Cited: 13
Liver and inflammatory biomarker relationships to depression symptoms in healthy older adults
Karen Savage, Claire Porter, Emily Bunnett, et al.
Experimental Gerontology (2023) Vol. 177, pp. 112186-112186
Open Access | Times Cited: 12
Differentiating melancholic and non-melancholic depression via biological markers: A review
Michael J. Spoelma, Anastasia Serafimovska, Gordon Parker
The World Journal of Biological Psychiatry (2023) Vol. 24, Iss. 9, pp. 761-810
Open Access | Times Cited: 11
Identification of mitophagy-related biomarkers and immune infiltration in major depressive disorder
Jing Zhang, Shujun Xie, Rong Xiao, et al.
BMC Genomics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Atrophy of bilateral nucleus accumbens in melancholic depression
Zhaosong Chu, Lijin Yuan, Mengxin He, et al.
Neuroreport (2023) Vol. 34, Iss. 10, pp. 493-500
Closed Access | Times Cited: 10
Flavins and Flavoproteins in the Neuroimmune Landscape of Stress Sensitization and Major Depressive Disorder
Matt Scott Schrier, M. Smirnova, Daniel P. Nemeth, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 681-699
Open Access
Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning
Yolanda Sánchez‐Carro, Alejandro de la Torre‐Luque, Itziar Leal‐Leturia, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 121, pp. 110674-110674
Open Access | Times Cited: 15
Major Depressive Disorder in Older Patients as an Inflammatory Disorder: Implications for the Pharmacological Management of Geriatric Depression
Malcolm Forbes, Adrienne O’Neil, Melissa M. Lane, et al.
Drugs & Aging (2021) Vol. 38, Iss. 6, pp. 451-467
Closed Access | Times Cited: 20
TNF-α, IL-6 and hsCRP in patients with melancholic, atypical and anxious depression: an antibody array analysis related to somatic symptoms
Hongmei Liu, Xiaohui Wu, Yun Wang, et al.
General Psychiatry (2022) Vol. 35, Iss. 4, pp. e100844-e100844
Open Access | Times Cited: 13
The effect of mindfulness on the inflammatory, psychological and biomechanical domains of adult patients with low back pain: A randomized controlled clinical trial
Gustavo G. Díez, Eduardo Anitua, Nazareth P. Castellanos, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0276734-e0276734
Open Access | Times Cited: 12
Combined serum IL-6, C-reactive protein, and cortisol may distinguish patients with anhedonia in major depressive disorder
Yinghui Li, Yingying Yue, Suzhen Chen, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top